Addiction Nicotine study: VapeAway filter system
Official title The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
ClinicalTrials.gov ID: NCT07322432
What this study is testing
- What it's testing
- The study wants to see if the VapeAway system can help adults stop vaping and be safe. It will compare quitting rates to the usual 7% quit rate.
- Who it's for
- Adults who currently vape nicotine e‑cigarettes and want to quit.
- What's involved
- Participants will use special filters, a handheld device called Fix Bar, and follow a digital support plan for about 42 days, while recording each vaping session.
- Time commitment
- The trial lasts roughly 6 weeks with regular check‑ins and data collection during that period.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Age: Adults aged 21 years and older
- Current Vaping Behavior: Daily or near-daily use (≥5 days/week or at least 20 days per month) of nicotine-containing e-cigarettes for at least the...
- Score of 4 or 5 on all 5-point Likert-type scale questions (see appendix)
- Score of 6 or 7 on Motivation To Stop Scale (MTSS) (see appendix)
- Participants must be classified in the Preparation stage of the Transtheoretical Model of behavior change (see appendix)
You likely can't join if
- PHQ-2 score ≥ 2 (see appendix)
- GAD-2 score ≥ 2 (see appendix)
- Use of any nicotine products except for vaping, including combustible tobacco (e.g., cigarettes) or other non-e-cigarette nicotine delivery systems...
- Self-reported or medically diagnosed substance use disorder (excluding nicotine), unless in sustained remission (\>12 months).
- Illicit drug use in the past 60 days
- Screening positive for alcohol use disorder in past year
See the full eligibility criteria
- Age: Adults aged 21 years and older
- Current Vaping Behavior: Daily or near-daily use (≥5 days/week or at least 20 days per month) of nicotine-containing e-cigarettes for at least the past 3 months.
- Score of 4 or 5 on all 5-point Likert-type scale questions (see appendix)
- Score of 6 or 7 on Motivation To Stop Scale (MTSS) (see appendix)
- Participants must be classified in the Preparation stage of the Transtheoretical Model of behavior change (see appendix)
- Saliva Cotinine level ≥ 10 ng/ml
- Penn State Electronic Cigarette Dependence Index (PSECDI) of at least 4 and above
- Willingness to participate in the study and all study requirements
- Willingness to not use any other nicotine-containing products for the duration of the study
- Ability to attend visits and provide informed consent
- PHQ-2 score ≥ 2 (see appendix)
- GAD-2 score ≥ 2 (see appendix)
- Use of any nicotine products except for vaping, including combustible tobacco (e.g., cigarettes) or other non-e-cigarette nicotine delivery systems within the past 30-days
- Self-reported or medically diagnosed substance use disorder (excluding nicotine), unless in sustained remission (\>12 months).
- Illicit drug use in the past 60 days
- Screening positive for alcohol use disorder in past year
- Any serious medical condition or medication that would contraindicate participation in a behavioral cessation trial (to be defined and assessed by study physician or PI).
- Pregnant or breastfeeding
- Symptomatic cardiovascular disease
- Participation in another smoking/vaping cessation trial
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.